Fused aromatic PTP-1B inhibitors

Details for Australian Patent Application No. 2008209296 (hide)

Owner Merck Frosst Canada Ltd.

Inventors Belley, Michel; Dufresne, Claude; Lau, Cheuk K.; Colucci, John; Bayly, Christopher; Wilson, Marie-Claire; Han, Yongxin

Agent Spruson & Ferguson

Pub. Number AU-A-2008209296

PCT Pub. Number WO2008/089581

Priority 60/897,700 26.01.07 US

Filing date 24 January 2008

Wipo publication date 31 July 2008

International Classifications

C07F 9/60 (2006.01) Compounds containing elements of the 5th Group of the Periodic System

A61K 31/662 (2006.01) - Phosphorus acids or esters thereof having PC bonds, e.g. foscarnet, trichlorfon

A61K 31/675 (2006.01) - having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 35/00 (2006.01) Antineoplastic agents

C07F 9/38 (2006.01) Compounds containing elements of the 5th Group of the Periodic System

C07F 9/40 (2006.01) Compounds containing elements of the 5th Group of the Periodic System

Event Publications

30 July 2009 PCT application entered the National Phase

  PCT publication WO2008/089581 Priority application(s): WO2008/089581

12 April 2012 Alteration of Name

  The name of the applicant has been altered to Kaneq Pharma Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008209302-Device for the contactless determination of the energy requirements of a point actuating drive

2008209295-Azacycloalkane derivatives as inhibitors of stearoyl-coenzyme A delta-9 desaturase